Jennifer R. Cochran

Entity
Individual
Business address
C/O Ligand Pharmaceuticals Inc, 3911 Sorrento Valley Boulevard, Ste 100, 92121 San Diego, CA
Signature Ownership
By: /s/ Charles S. Berkman, Attorney-in-Fact For: Jennifer R. Cochran
All SEC filings
View on sec.gov
Get insider transactions for this reporting owner
Jennifer R. Cochran has filed 16 SEC EDGAR filings since 7/14/2021

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing FORM 4 Jun 18, 2025 Jun 17, 2025 001-40720
4 Open Document Open Filing FORM 4 May 15, 2025 May 15, 2025 001-40720
4 Open Document Open Filing FORM 4 Jul 12, 2024 Jul 12, 2024 001-40720
4 Open Document Open Filing FORM 4 Jun 21, 2024 Jun 18, 2024 001-40720
4/A Open Document Open Filing FORM 4/A Apr 23, 2024 Nov 1, 2022 001-40720
4 Open Document Open Filing PRIMARY DOCUMENT Jul 14, 2023 Jul 12, 2023 001-40720
4 Open Document Open Filing PRIMARY DOCUMENT Jun 27, 2023 Jun 23, 2023 001-40720
4 Open Document Open Filing PRIMARY DOCUMENT Feb 1, 2023 Jan 30, 2023 001-40720
4 Open Document Open Filing FORM 4 SUBMISSION Dec 8, 2022 Dec 6, 2022 001-40720
4 Open Document Open Filing FORM 4 SUBMISSION Nov 14, 2022 Nov 11, 2022 001-40720
4 Open Document Open Filing FORM 4 SUBMISSION Nov 3, 2022 Nov 1, 2022 001-40720
4 Open Document Open Filing FORM 4 SUBMISSION Nov 3, 2022 Nov 1, 2022 001-33093
3 Open Document Open Filing FORM 3 SUBMISSION Nov 3, 2022 Nov 1, 2022 001-40720
4 Open Document Open Filing PRIMARY DOCUMENT Jun 13, 2022 Jun 10, 2022 001-33093
4 Open Document Open Filing PRIMARY DOCUMENT Jul 14, 2021 Jul 12, 2021 001-33093
3 Open Document Open Filing PRIMARY DOCUMENT Jul 14, 2021 Jul 12, 2021 001-33093